Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | HTR6 | P50406 | 1/20 | 0.46 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | MMP1 | P03956 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 1/20 | 0.43 |
| ▸ | MMP9 | P14780 | 1/20 | 0.43 |
| ▸ | MMP8 | P22894 | 1/20 | 0.43 |
| ▸ | MMP13 | P45452 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29741753 | 0.82 | LMNA (0.46) | TSHRSMN1; SMN2HTR6PSIP1CA1 | |
| SCHEMBL778854 | 0.80 | HTR6 (0.50) | TSHRSMN1; SMN2HTR6PSIP1CA1 | |
| SCHEMBL4327138 | 0.80 | HTR6 (0.50) | TSHRSMN1; SMN2HTR6PSIP1CA1 | |
| SCHEMBL5664473 | 0.80 | MMP2 (0.50) | TSHRHTR6MMP1MMP2MMP9 | |
| SCHEMBL5335059 | 0.79 | GAA (0.52) | SMN1; SMN2CA1CA2CA12CA9 | |
| SCHEMBL10767053 | 0.79 | SMN1; SMN2 (0.41) | TSHRSMN1; SMN2HTR6PSIP1CA1 | |
| SCHEMBL3328703 | 0.78 | HTR6 (0.48) | TSHRSMN1; SMN2HTR6PSIP1CA1 | |
| SCHEMBL10650374 | 0.78 | MMP2 (0.40) | CA1CA2CA12CA9KDM4E | |
| SCHEMBL28902110 | 0.77 | TSHR (0.70) | TSHRSMN1; SMN2HTR6PSIP1CA1 | |
| SCHEMBL7758469 | 0.77 | TSHR (0.52) | TSHRSMN1; SMN2HTR6CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003050094-A1 | REACTIVE LIQUID POLYMER CROSSLINKING AGENT AND PROCESS FOR PREPARATION | LCB WORLDWIDE INC. (US) | 2003-06-19 | — | — | WO | claimed |
| EP-0602914-B1 | Ink compositions for ink jet printing | XEROX CORP (US) | 1997-11-12 | — | — | EP | claimed |
| US-5300143-A | Water soluble dye, sulfone, and amide or cyclic amine | XEROX CORPORATION (US) | 1994-04-05 | — | — | US | claimed |
| US-20240241440-A1 | POLYMER, PHOTORESIST COMPOSITIONS INCLUDING THE SAME, AND PATTERN FORMATION METHODS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2024-07-18 | — | — | US | disclosed |
| CN-118287092-A | Sulfur-resistant catalyst for nitro catalytic hydrogenation and preparation method and application thereof | 大连理工大学 | 2024-07-05 | — | — | CN | disclosed |
| US-20230212212-A1 | PROCESSES FOR PREPARING OLIGONUCLEOTIDES | SHANGHAI STA PHARMACEUTICAL R&D CO., LTD. (CN) | 2023-07-06 | — | — | US | disclosed |
| EP-4182315-A1 | PROCESSES FOR PREPARING OLIGONUCLEOTIDES | Changzhou Syntheall Pharmaceuticals Co., Ltd. (CN) | 2023-05-24 | — | — | EP | disclosed |
| WO-2022006871-A1 | PROCESSES FOR PREPARING OLIGONUCLEOTIDES | CHANGZHOU SYNTHEALL PHARMACEUTICALS CO., LTD. (CN) | 2022-01-13 | — | — | WO | disclosed |
| CN-106496367-A | Catalytic component and its preparation and application for olefinic polymerization | 中国石油化工股份有限公司 | 2017-03-15 | — | — | CN | disclosed |
| CN-103509135-B | Olefin polymerization catalyst component, preparation method and application thereof | CHINA PETROLEUM & CHEMICAL | 2015-07-22 | — | — | CN | disclosed |
| EP-2177519-B1 | TETRAZOYLOXIME DERIVATIVE AND PLANT DISEASE CONTROL AGENT | NIPPON SODA CO (JP) | 2015-05-27 | — | — | EP | disclosed |
| EP-0382185-B1 | Carbostyril derivatives | OTSUKA PHARMA CO LTD (JP) | 1994-06-15 | — | — | EP | disclosed |
| US-5300143-A | Water soluble dye, sulfone, and amide or cyclic amine | XEROX CORPORATION (US) | 1994-04-05 | — | — | US | disclosed |
| WO-1994001113-A1 | OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1994-01-20 | — | — | WO | disclosed |
| US-5225402-A | Vasopressin antagonist, vasodilation, hypotensive, diuretics and anticoagulants | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-07-06 | — | — | US | disclosed |
| US-4754071-A | Process for preparing aryl hydroxyethyl sulfones | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-06-28 | — | — | US | disclosed |
| US-4695639-A | Thiazole derivatives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1987-09-22 | — | — | US | disclosed |
| EP-0115770-B1 | THIAZOLE DERIVATIVES | Takeda Chemical Industries, Ltd. (JP) | 1987-07-22 | — | — | EP | disclosed |
| EP-0163996-A1 | 2,2-Dimethyl-3-formylcyclopropanes and process for their preparation | BAYER AG (DE) | 1985-12-11 | — | — | EP | disclosed |
| US-4157915-A | (2-BENZENESULFONYL)-ETHOXYCARBONYLAMINO-ANILINE COMPOUND AS THE PRECURSOR | FUJI PHOTO FILM CO., LTD. (JP) | 1979-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212212-A1 | PROCESSES FOR PREPARING OLIGONUCLEOTIDES | XRN2, UPF1, NSUN2 | TSHR 2967/4885SMN1; SMN2 127/4885HTR6 4699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.